92 related articles for article (PubMed ID: 8025579)
1. Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE).
Arden NK; Lloyd ME; Spector TD; Hughes GR
Lupus; 1994 Feb; 3(1):11-3. PubMed ID: 8025579
[TBL] [Abstract][Full Text] [Related]
2. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.
Buyon JP; Petri MA; Kim MY; Kalunian KC; Grossman J; Hahn BH; Merrill JT; Sammaritano L; Lockshin M; Alarcón GS; Manzi S; Belmont HM; Askanase AD; Sigler L; Dooley MA; Von Feldt J; McCune WJ; Friedman A; Wachs J; Cronin M; Hearth-Holmes M; Tan M; Licciardi F
Ann Intern Med; 2005 Jun; 142(12 Pt 1):953-62. PubMed ID: 15968009
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy in systemic lupus erythematosus.
Kreidstein S; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1997 Nov; 24(11):2149-52. PubMed ID: 9375875
[TBL] [Abstract][Full Text] [Related]
4. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus.
Mok CC; Lau CS; Ho CT; Lee KW; Mok MY; Wong RW
Scand J Rheumatol; 1998; 27(5):342-6. PubMed ID: 9808396
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women.
Fernández M; Calvo-Alén J; Bertoli AM; Bastian HM; Fessler BJ; McGwin G; Reveille JD; Vilá LM; Alarcón GS
J Clin Rheumatol; 2007 Oct; 13(5):261-5. PubMed ID: 17921793
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus.
Buyon JP
J Am Med Womens Assoc (1972); 1998; 53(1):13-7. PubMed ID: 9458619
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.
Hochman J; Urowitz MB; Ibañez D; Gladman DD
Lupus; 2009 Apr; 18(4):313-7. PubMed ID: 19276299
[TBL] [Abstract][Full Text] [Related]
8. Use of exogenous estrogens in systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
Semin Arthritis Rheum; 2001 Jun; 30(6):426-35. PubMed ID: 11404826
[TBL] [Abstract][Full Text] [Related]
9. Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis.
Rojas-Villarraga A; Torres-Gonzalez JV; Ruiz-Sternberg ÁM
PLoS One; 2014; 9(8):e104303. PubMed ID: 25137236
[TBL] [Abstract][Full Text] [Related]
10. [Estrogen use in systemic lupus erythematosus].
Ketari S; Cherif O; Boussema F; Kochbati S; Ben Dhaou B; Rokbani L
Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
[TBL] [Abstract][Full Text] [Related]
11. [Use of estrogen in women with systemic lupus erythematosus--should, should not?].
Ostensen M
Tidsskr Nor Laegeforen; 1996 Nov; 116(27):3237-9. PubMed ID: 9011978
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus.
Meier CR; Sturkenboom MC; Cohen AS; Jick H
J Rheumatol; 1998 Aug; 25(8):1515-9. PubMed ID: 9712093
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and venous thromboembolism.
Eisenberger A; Westhoff C
J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
[TBL] [Abstract][Full Text] [Related]
14. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism in users of hormone replacement therapy.
Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus.
Lakshminarayanan S; Walsh S; Mohanraj M; Rothfield N
J Rheumatol; 2001 Jan; 28(1):102-8. PubMed ID: 11196509
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
Sánchez-Guerrero J; Liang MH; Karlson EW; Hunter DJ; Colditz GA
Ann Intern Med; 1995 Mar; 122(6):430-3. PubMed ID: 7856991
[TBL] [Abstract][Full Text] [Related]
18. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy.
Petri M
Lupus; 2001; 10(3):222-6. PubMed ID: 11315357
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
20. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
